These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15037537)

  • 21. Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha/gamma and COX-2/mPGES-1-mediated pathways in macrophages derived from THP-1 cells.
    Xue J; Hua YN; Xie ML; Gu ZL
    Biomed Pharmacother; 2010 Feb; 64(2):118-23. PubMed ID: 19880272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
    Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
    Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells.
    Kojima F; Naraba H; Sasaki Y; Okamoto R; Koshino T; Kawai S
    J Rheumatol; 2002 Sep; 29(9):1836-42. PubMed ID: 12233875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2.
    Bosetti F; Langenbach R; Weerasinghe GR
    J Neurochem; 2004 Dec; 91(6):1389-97. PubMed ID: 15584915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques.
    Cipollone F; Fazia M; Mincione G; Iezzi A; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; Di Nisio M; Cuccurullo F; Mezzetti A; Porreca E
    Stroke; 2004 Oct; 35(10):2253-7. PubMed ID: 15297631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lesion progression in apoE-deficient mice: implication of chemokines and effect of the AT1 angiotensin II receptor antagonist irbesartan.
    Martin G; Dol F; Marés AM; Berezowski V; Staels B; Hum DW; Schaeffer P; Herbert JM
    J Cardiovasc Pharmacol; 2004 Feb; 43(2):191-9. PubMed ID: 14716205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation.
    Clancy P; Koblar SA; Golledge J
    Atherosclerosis; 2014 Sep; 236(1):108-15. PubMed ID: 25016365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer.
    Yoshimatsu K; Golijanin D; Paty PB; Soslow RA; Jakobsson PJ; DeLellis RA; Subbaramaiah K; Dannenberg AJ
    Clin Cancer Res; 2001 Dec; 7(12):3971-6. PubMed ID: 11751489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis.
    van Oostrom O; Velema E; Schoneveld AH; de Vries JP; de Bruin P; Seldenrijk CA; de Kleijn DP; Busser E; Moll FL; Verheijen JH; Virmani R; Pasterkamp G
    Cardiovasc Pathol; 2005; 14(3):126-34. PubMed ID: 15914297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between 5-lipoxygenase expression and plaque instability in humans.
    Cipollone F; Mezzetti A; Fazia ML; Cuccurullo C; Iezzi A; Ucchino S; Spigonardo F; Bucci M; Cuccurullo F; Prescott SM; Stafforini DM
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1665-70. PubMed ID: 15933245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2.
    Murakami M; Naraba H; Tanioka T; Semmyo N; Nakatani Y; Kojima F; Ikeda T; Fueki M; Ueno A; Oh S; Kudo I
    J Biol Chem; 2000 Oct; 275(42):32783-92. PubMed ID: 10869354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression.
    Sapienza P; di Marzo L; Borrelli V; Sterpetti AV; Mingoli A; Piagnerelli R; Cavallaro A
    Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):89-97. PubMed ID: 15177237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries.
    Stemme V; Swedenborg J; Claesson H; Hansson GK
    Eur J Vasc Endovasc Surg; 2000 Aug; 20(2):146-52. PubMed ID: 10942685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial Protection, AT1 blockade and Cholesterol-Dependent Oxidative Stress: the EPAS trial.
    Morawietz H; Erbs S; Holtz J; Schubert A; Krekler M; Goettsch W; Kuss O; Adams V; Lenk K; Mohr FW; Schuler G; Hambrecht R
    Circulation; 2006 Jul; 114(1 Suppl):I296-301. PubMed ID: 16820589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment.
    Marfella R; D'Amico M; Di Filippo C; Baldi A; Siniscalchi M; Sasso FC; Portoghese M; Carbonara O; Crescenzi B; Sangiuolo P; Nicoletti GF; Rossiello R; Ferraraccio F; Cacciapuoti F; Verza M; Coppola L; Rossi F; Paolisso G
    J Am Coll Cardiol; 2006 Jun; 47(12):2444-55. PubMed ID: 16781372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability.
    Sigala F; Kotsinas A; Savari P; Filis K; Markantonis S; Iliodromitis EK; Gorgoulis VG; Andreadou I
    J Vasc Surg; 2010 Sep; 52(3):704-13. PubMed ID: 20573470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines.
    van Rees BP; Sivula A; Thorén S; Yokozaki H; Jakobsson PJ; Offerhaus GJ; Ristimäki A
    Int J Cancer; 2003 Nov; 107(4):551-6. PubMed ID: 14520691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene.
    Gosset M; Berenbaum F; Levy A; Pigenet A; Thirion S; Saffar JL; Jacques C
    Arthritis Res Ther; 2006; 8(4):R135. PubMed ID: 16872525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.